Trending...
- Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 348
- MROVI Trailer Parts Launches Its Own Tire Brand: Introducing MROVI Tires and the New Didgori Trail Tread
- Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the 7th Annual Evercore HealthCONx Conference in Miami on Tuesday, December 3, 2024, at 3:25 p.m. ET.
For investors interested in scheduling a one-on-one meeting with the Remix management team, please contact your Evercore representative.
About Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease. The REMaster™ technology platform facilitates RNA processing pattern identification, leveraging these learnings to modulate gene expression. Remix's innovative therapeutic approach has the potential to alter the way genes are read from the genome, to correct, enhance, or eliminate the gene message, thereby addressing disease drivers at their origin. For more information visit www.remixtx.com.
More on The Floridant
Contacts:
Media Contact:
Peg Rusconi
Deerfield Group
[email protected]
Investor Contact:
Will O'Connor
Precision AQ
[email protected]
SOURCE Remix Therapeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
For investors interested in scheduling a one-on-one meeting with the Remix management team, please contact your Evercore representative.
About Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease. The REMaster™ technology platform facilitates RNA processing pattern identification, leveraging these learnings to modulate gene expression. Remix's innovative therapeutic approach has the potential to alter the way genes are read from the genome, to correct, enhance, or eliminate the gene message, thereby addressing disease drivers at their origin. For more information visit www.remixtx.com.
More on The Floridant
- Tampa Bay Shine Expands Home and Commercial Cleaning Services Across Tampa Bay
- Warrior Homes of Collier receives $50,000 Continuum of Care grant
- Community Partners of South Florida Names Amy Brand Vice President of Advancement
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Bay Street Yard to host Fa La La Family Nights Dec. 9 and 16
Contacts:
Media Contact:
Peg Rusconi
Deerfield Group
[email protected]
Investor Contact:
Will O'Connor
Precision AQ
[email protected]
SOURCE Remix Therapeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
Filed Under: Business
0 Comments
Latest on The Floridant
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- InGate Consulting Launches in Tampa Bay, Bringing Elite-Level Influence, Strategic Introductions, and High-Impact Business Connections to the Region
- Rich Noto Introduces Enhanced Construction-Focused Realtor Services in Florida
- Steady Café & Comedy Debuts as First Diabetic-Friendly Café Chain with Investor Openings
- She Hacked the Algorithm That Keeps You Scrolling to Fix Network Marketing's Biggest Problems
- The Counseling Center of New Smyrna Beach Expands Access To Counseling Services
- Florida Trust Wealth Management sponsors CHR's 2025 Festival of Trees
- InsideOut Aesthetics & Wellness Expands Services With New Cynosure XERF and LaseMD Ultra Laser Systems
- Local Fiber Announces Graduation from Samsung Next Startup Program, Marks New Phase of Growth
- Inaugural ParrotPHest raises $7,000 for Alzheimer's Association
- Florida: Governor Ron DeSantis Awards $112 Million for Water Quality and Supply Projects Statewide
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- Better Together receives $5,000 at the Dr. Phillips Charities Impact Awards
- Community of Seven Pines achieves milestones
- Southwest Florida Housing Foundation launches 'Future Forward Scholarship Program'
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- Polk County Bail Bondsman Doug Moore Appointed Membership Chair of Florida Bail Agents Association